Literature DB >> 15099149

Sensitivity to expectancy violations in healthy aging and mild cognitive impairment.

Juliet E Davie1, Tamiko Azuma, Stephen D Goldinger, Donald J Connor, Marwan N Sabbagh, Nina B Silverberg.   

Abstract

In this study, individuals with mild cognitive impairment (MCI) were tested to see if executive dysfunction impacts their implementation of expectancy biases in a priming task. Young adults, healthy older adults, and individuals with MCI made speed-related decisions to sequentially presented word pairs. The proportion of category related (e.g., apple-fruit) versus coordinate related (apple-pear) pairs was varied to create different expectancy biases. When the proportion of category pairs was high (80%), the control groups showed an expectancy bias: Significant inhibition was observed for coordinate pairs compared with category pairs. The MCI group also demonstrated an expectancy bias but with much larger costs for unexpected targets. The findings suggest that individuals with MCI are inordinately sensitive to expectancy violations, and these findings are discussed in terms of possible executive dysfunction.

Entities:  

Mesh:

Year:  2004        PMID: 15099149     DOI: 10.1037/0894-4105.18.2.269

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  3 in total

1.  MCI is associated with deficits in everyday functioning.

Authors:  Sarah T Farias; Dan Mungas; Bruce R Reed; Danielle Harvey; Deborah Cahn-Weiner; Charles Decarli
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

2.  Judgment in older adults: development and psychometric evaluation of the Test of Practical Judgment (TOP-J).

Authors:  L A Rabin; M J Borgos; A J Saykin; H A Wishart; P K Crane; K E Nutter-Upham; L A Flashman
Journal:  J Clin Exp Neuropsychol       Date:  2007-10       Impact factor: 2.475

3.  Electrophysiological correlates of amnestic mild cognitive impairment in a simon task.

Authors:  Jesús Cespón; Santiago Galdo-Álvarez; Fernando Díaz
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.